Attention-Deficit/Hyperactivity Disorder (ADHD) Protocol
Primary Stack
Core supplements with strongest evidenceEssential for brain structure and function; EPA and DHA support neurotransmitter activity and reduce neuroinflammation
Essential for dopamine regulation; deficiency common in ADHD; may enhance medication response
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsRequired for dopamine synthesis; low ferritin associated with worse ADHD symptoms
Supporting Studies (1)
Calming effect on nervous system; deficiency common in ADHD; supports neurotransmitter function
Supporting Studies (1)
Supports neuronal membrane function and neurotransmitter activity; may improve attention and memory
Supporting Studies (1)
Supports brain energy metabolism and acetylcholine production; may improve attention
Supporting Studies (1)
Deficiency associated with ADHD; vitamin D receptors in brain areas involved in attention
Supporting Studies (1)
How This Protocol Works
Simple Explanation
ADHD is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects brain regions involved in executive function and uses dopamine and norepinephrine as key neurotransmitters. While stimulant medications are the most effective treatment, certain nutritional deficiencies are more common in ADHD and addressing them may help reduce symptoms.
IMPORTANT: These supplements are meant to complement, not replace, evidence-based ADHD treatment. Stimulant and non-stimulant medications remain the most effective treatments. Always work with your healthcare provider.
Expected timeline: Omega-3s: 8-12 weeks. Zinc/Iron (if deficient): 4-8 weeks. Magnesium: 2-4 weeks. Best approach is to test for deficiencies and correct them while continuing evidence-based treatments.
Clinical Perspective
ADHD is characterized by developmentally inappropriate levels of inattention, hyperactivity, and impulsivity. Neurobiologically, it involves prefrontal cortex hypofunction, altered dopaminergic and noradrenergic neurotransmission, and structural/functional brain differences. First-line treatments are stimulant medications (methylphenidate, amphetamines) with response rates of 70-80%. This protocol addresses nutritional factors that may modulate neurotransmitter function and brain development.
CRITICAL: Supplements are adjunctive to behavioral therapy and medication. Screen for nutritional deficiencies (iron, zinc, omega-3 index) before supplementation. Monitor for interactions with ADHD medications.
Biomarker targets: Ferritin (>30-50 ng/mL), serum zinc, 25(OH)D (>30 ng/mL), RBC omega-3 index (>8%), ADHD rating scales (Conners, SNAP-IV), academic performance metrics.
Protocol notes: Behavioral therapy (parent training, organizational skills training) is evidence-based. Stimulant medications (methylphenidate, amphetamines) remain most effective treatment. Non-stimulants (atomoxetine, guanfacine, viloxazine) are alternatives. Elimination diets (few foods diet) help subset of children—consider if family history of food sensitivity. Artificial food colors may worsen symptoms in some. Regular exercise improves executive function. Adequate sleep critical—address sleep disorders. Screen for comorbidities (anxiety, depression, learning disorders). Avoid marketing hype around 'natural ADHD cures'—most lack evidence. Mediterranean-style diet pattern associated with lower ADHD risk.